Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose

19Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

Objective: Type 1 and 2 diabetes are characterized by elevated blood glucose levels and increased dipeptidyl peptidase 4 (DPP4) activity levels in the serum. However, previous studies reported a negative correlation between glucose concentrations and DPP4 levels. The purpose of this study was to elucidate the connection between glucose and DPP4 in adipocytes under physiological and diabetic conditions, because DPP4 is an adipokine. Methods: Blood glucose and serum DPP4 levels were measured, and adipocytes were collected from mice under normal, high-fat diet fed, and diabetic conditions. The adipocytes obtained were incubated for 24 hours in medium containing 5.5 or 25 mM glucose, and 3T3-L1 preadipocytes were differentiated under 5.5 or 25 mM glucose. Adipocytes from mice and 3T3-L1 were stimulated by tumor necrosis factor-α (TNF-α) for 24 hours. The levels of released and intracellular DPP4 were determined by enzyme-linked immunosorbent assay. Results: Mice fed high-fat diet had lower serum DPP4 levels in the first and second week than controls. However, this difference gradually disappeared over 6 weeks. The differentiation of 3T3-L1 adipocytes under 25 mM glucose produced lower DPP4 levels than those differentiated under 5.5 mM; this was also observed in isolated adipocytes from mice. However, these effects of glucose were lost in adipocytes from diabetic mice, and an increase in total DPP4 levels was observed. The stimulation of adipocytes with TNF-α increased the release of DPP4 irrespective of glucose concentration. Conclusion: The production of DPP4 in adipocytes was negatively regulated by 25 mM glucose under physiological conditions, but not in diabetic mice. Our results suggest that the observed increase in serum DPP4 levels may be attributed to increased production of DPP4 in adipocytes and an enhancement in TNF-α-induced release. © 2014 Das et al. This work is published by Dove Medical Press Limited.

Author supplied keywords

References Powered by Scopus

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

3391Citations
N/AReaders
Get full text

Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome

515Citations
N/AReaders
Get full text

Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?

221Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Adipokines in health and disease

827Citations
N/AReaders
Get full text

Genome-wide analysis reveals adaptation to high altitudes in Tibetan sheep

112Citations
N/AReaders
Get full text

Antidiabetic treatment with gliptins: Focus on cardiovascular effects and outcomes

70Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Das, S. S., Hayashi, H., Sato, T., Yamada, R., Hiratsuka, M., & Hirasawa, N. (2014). Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose. Diabetes, Metabolic Syndrome and Obesity, 7, 185–194. https://doi.org/10.2147/DMSO.S62610

Readers over time

‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

50%

Professor / Associate Prof. 5

25%

Researcher 5

25%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 8

40%

Biochemistry, Genetics and Molecular Bi... 6

30%

Medicine and Dentistry 4

20%

Pharmacology, Toxicology and Pharmaceut... 2

10%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 1

Save time finding and organizing research with Mendeley

Sign up for free
0